Anaemia Clinical Trials

104 clinical trials for Anaemia across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study — RECRUITING · PHASE3
• Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions. — RECRUITING
• Determining haematologic reference values for older out-patients >= 70 years in Germany: a retrospective analysis — RECRUITING
• Treatment of a low blood count before heart surgery comparing iron supplements taken by mouth and the combination of iron given by intravenous drip and a drug to increase the blood count — COMPLETED · PHASE2
• PREVENTT (Preoperative intravenous iron to treat anaemia in major surgery) — COMPLETED · PHASE3
• Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients. — COMPLETED · PHASE4
• Tranexamic Acid for Anaemia Trial — NOT_YET_RECRUITING · PHASE3
• Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia — TERMINATED · PHASE2
• The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly — COMPLETED · PHASE1
• Transfusion Practices in Intensive Care Units: a Hungarian Nationwide Survey — COMPLETED
• ScvO2-Centered Optimisation of RED Blood Cell Transfusions — NOT_YET_RECRUITING · NA
• Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery — COMPLETED · PHASE4
• A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) — NOT_YET_RECRUITING · PHASE3
• Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. — NOT_YET_RECRUITING · PHASE3
• Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard — TERMINATED · NA
• Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) — COMPLETED · PHASE3
• Correction of Anaemia and Progression of Renal Failure on Transplanted Patients — COMPLETED · PHASE4
• South African Paediatric Surgical Outcomes Study 2 — COMPLETED · PHASE4
• the MCCE vs EGD Trial — NOT_YET_RECRUITING · NA
• Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso — COMPLETED
• Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants — COMPLETED · PHASE1
• Study on Effect of Papworth Technique in Anemic Asthmatic Pediatrics — NOT_YET_RECRUITING · NA
• Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets — COMPLETED · NA
• Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia — COMPLETED · PHASE1
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — COMPLETED · PHASE3
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) — COMPLETED · PHASE3
• Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) — TERMINATED · PHASE2
• Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) — COMPLETED · PHASE2
• The UK CAVIAR Study — COMPLETED
• Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product — COMPLETED · NA
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — COMPLETED · PHASE3
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) — COMPLETED · PHASE3
• Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) — COMPLETED · PHASE3
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) — COMPLETED · PHASE3
• Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP) — COMPLETED · PHASE2
• Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia — COMPLETED · PHASE3
• Treatment Response in Dialysis Anaemia — COMPLETED · PHASE4
• A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) — COMPLETED · PHASE3
• Daprodustat Bioequivalence and Food Effect Study — COMPLETED · PHASE1
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent — COMPLETED · PHASE2
• Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents — COMPLETED · PHASE3
• Absorption and Elimination of Radiolabeled Daprodustat — COMPLETED · PHASE1
• Daprodustat Hepatic Impairment Study — COMPLETED · PHASE1
• Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment — TERMINATED · PHASE1
• Preoperative Intravenous Iron to Treat Anaemia in Major Surgery — COMPLETED · PHASE3
• Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis — COMPLETED · PHASE1
• Multiple Ascending Dose Study of DS-1093 in Healthy Subjects — COMPLETED · PHASE1
• Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women — WITHDRAWN · NA
• A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD) — COMPLETED · PHASE2
• Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers — COMPLETED · PHASE1

Refine this search